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Abstract 
Purpose: Very old critical ill patients are a rapid expanding group in the ICU. Indications for admission, triage criteria 
and level of care are frequently discussed for such patients. However, most relevant outcome studies in this group 
frequently find an increased mortality and a reduced quality of life in survivors. The main objective was to study the 
impact of frailty compared with other variables with regards to short-term outcome in the very old ICU population.
Methods: A transnational prospective cohort study from October 2016 to May 2017 with 30 days follow-up was set 
up by the European Society of Intensive Care Medicine. In total 311 ICUs from 21 European countries participated. The 
ICUs included the first consecutive 20 very old (≥ 80 years) patients admitted to the ICU within a 3-month inclusion 
period. Frailty, SOFA score and therapeutic procedures were registered, in addition to limitations of care. For measure-
ment of frailty the Clinical Frailty Scale was used at ICU admission. The main outcomes were ICU and 30-day mortality 
and survival at 30 days.
Results: A total of 5021 patients with a median age of 84 years (IQR 81–86 years) were included in the final analysis, 
2404 (47.9%) were women. Admission was classified as acute in 4215 (83.9%) of the patients. Overall ICU and 30-day 
mortality rates were 22.1% and 32.6%. During ICU stay 23.8% of the patients did not receive specific ICU procedures: 
ventilation, vasoactive drugs or renal replacement therapy. Frailty (values ≥ 5) was found in 43.1% and was indepen-
dently related to 30-day survival (HR 1.54; 95% CI 1.38–1.73) for frail versus non-frail.
Conclusions: Among very old patients (≥ 80 years) admitted to the ICU, the consecutive classes in Clinical Frailty 
Scale were inversely associated with short-term survival. The scale had a very low number of missing data. These find-
ings provide support to add frailty to the clinical assessment in this patient group.
Trial registration: ClinicalTrials.gov (ID: NCT03134807).
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Take-home message: This prospective multinational study of 5021 
very old intensive care patients (≥ 80 years) found frailty to be present 
in 43.1% and it was independently related to ICU (22.1%) and 30-day 
mortality (32.6%).
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Introduction
The increased demand for intensive care leaves many 
physicians with difficult decisions given the shortage of 
ICU beds in several countries. This is particularly true for 
“very old intensive care patients” (VIPs, ≥ 80 years old) 
partly because their life expectancy is limited. Are ICU 
admission and treatment proportional to their chances 
of survival? Indeed, all European countries are faced with 
this growing challenge related to these VIPs.
The triage process prior to admitting VIPs to the ICU 
differs from the less old, and should ideally use different 
tools than in younger patients [1]. At present, we have 
no ideal combination of independent prognostic factors 
associated with benefit from intensive care in this group. 
Even within a country there may be different opinions 
about the triage process. Other variables, apart from 
age, are important prognostic factors in the critically ill 
elderly patient, like co-morbidity and acute organ failure. 
Geriatric syndromes like frailty, sarcopenia, delirium and 
dementia probably play a major role as well. Frailty has 
been defined as a clinical state of increased vulnerabil-
ity from age-associated decline in physiological reserves 
and function in many physiological systems [2]. Although 
this concept of frailty is well established in the geriatric 
approach, it has only recently been used in ICU outcome 
studies [3].
Most publications on outcomes from intensive care in 
VIPs report a poor survival rate or a reduced quality of 
life in survivors [4–7], which is not merely dependent 
on the crude age of the patients. One-year mortality has 
been reported to reach 65% [8] and quality of life in sur-
vivors is significantly reduced in half of these survivors 
[4]. An international group of intensivists has recently 
proposed a research agenda for critically ill older patients 
[9]. Further documentation of the outcome of VIPs was 
deemed important, especially establishing the impor-
tance of factors like frailty and functional status.
The main objective of the present study was to study 
the occurrence of frailty and to assess its impact on 
30-day mortality in patients 80  years of age or older 
admitted to European ICUs. A secondary objective was 
to report the intensity of care and treatment restrictions 
while on the ICU in this patient group.
Methods
Design and setting
We conducted a prospective multicentre study in sev-
eral European countries. The study was coordinated 
through the Health Services Resource and Outcome 
(HSRO) section of the European Society of Intensive 
Care Medicine (ESICM). The ESICM network was used 
to disseminate information about the study. In most 
participating European countries, dedicated national 
coordinators were responsible for recruitment of ICUs, 
coordinated national and local ethical permissions and 
supervised patient recruitment at the national level. 
Institutional research ethic board approval was obtained 
from each study site. Because of the diversity of ethical 
consent procedures in Europe, many countries could 
recruit patients without informed consent while some 
had to collect informed consent. Each participating ICU 
could choose to include consecutive patients during an 
entire 3-month period, or to include the first 20 consecu-
tive patients within this period. Hence, units with many 
elderly patients could include more than 20 consecutive 
patients. Patients were followed until death or 30  days 
after ICU admission. Individual ICUs started the data 
collection between October 2016 and February 2017 
depending on the speed of local ethical clearance. A web-
site was set up to facilitate dissemination of information 
about the study and to allow for data entry using an elec-
tronic CRF. The week to week recruitment of patients at 
country level was displayed on the web page (ESM Fig. 1). 
The study was registered after start on ClinicalTrials.gov 
(ID: NCT03134807). No specific funding was received.
Study population
Consecutive patients of 80  years of age or older and 
admitted to the ICU were eligible, but pre-ICU triage 
was not registered. All reasons for ICU admissions were 
allowed and patients were grouped according to a prede-
fined list of 12 admission groups: respiratory failure, cir-
culatory failure, combined respiratory/circulatory failure, 
severe sepsis, severe trauma without head injury, severe 
trauma with head injury, isolated head injury, post elec-
tive surgery, intoxication, non-traumatic cerebral failure, 
post emergency surgery and other reasons. For the anal-
ysis in this paper patients were grouped into acute and 
elective (planned) admissions.
Data collection
The study collected a set of mandatory data (ESM 
Table  1) and allowed for optional registration of sever-
ity of illness scores. Length of stay (LOS) was recorded 
in hours, allowing calculation of length of stay in 24-h 
periods rather than in calendar days. Any period dur-
ing the ICU stay on non-invasive or invasive ventilation 
with endotracheal intubation or tracheotomy, use of 
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vasoactive drugs, and renal replacement therapy (RRT) 
qualified for use of that procedure/treatment. The SOFA 
score was calculated either manually or using an online 
calculator according to guidelines on admission [10].
The case record form and database ran on a secure 
server composed and stored in Aarhus University, 
Denmark. The servers were managed in co-operation 
between the Information Technology Department and 
the Department of Clinical Medicine.
Frailty
We defined this as the frailty level before the acute illness 
and hospital admission. The Clinical Frailty Scale (CFS) 
with simple visual description was used as a categorisa-
tion tool [11] and information necessary to perform this 
assessment by the ICU staff was given by patients or 
proxy. No particular training to use the CFS was deemed 
necessary since the description combined with illustra-
tions is intuitive. The English version of the CSF was used 
for this study. The CSF is composed of nine classes from 
very fit to terminally ill; hence the last group is techni-
cally speaking not necessarily frail (ESM Fig. 2).
Outcome measurement
The main outcome was survival at ICU discharge and at 
30 days after ICU admission. Data was retrieved from the 
hospital administration system in some units, but had to 
be collected using active follow-up in the rest. We also 
registered the use of four common ICU procedures dur-
ing the ICU stay, but not their duration. Whether treat-
ment was withheld or withdrawn was recorded and based 
on international recommendations [12].
Statistical analysis
No formal sample size calculation was performed for 
this observational study. Baseline patient characteristics, 
treatment and outcomes were compared between three 
frailty groups based on the CFS: not frail (scale 1–3), pre-
frail (scale 4) and frail (scale 5–9). Frailty was also ana-
lysed both using the whole scale as ordinal data, and after 
dichotomizing its presence, considering values of at least 
5 as frail as used in previous publications [3].
Continuous variables were compared between groups 
using Mann–Whitney U test and categorical variables 
were compared using the Chi square test. Normally dis-
tributed continuous data were described as means with 
95% CI and non-normal distributed data were described 
as median with 25–75 percentiles. For these analysis 
SPSS (IBM SPSS statistics, version 24) was used.
The crude overall survival at 30 days was estimated by 
the Kaplan–Meier method and compared with the use of 
a log-rank test. The adjusted impact of frailty on 30-day 
survival was estimated using a Cox model. Variables 
included in the model were age, gender, SOFA score, type 
of ICU admission (elective versus acute). The analysis 
was conducted on acute admission only and with inclu-
sion of geographical regions. A p value of less than 0.05 
was considered to indicate statistical significance. Analy-
ses were performed with R software, version 3.2.2 (The R 
Foundation).
Results
In total, 311 ICUs from 21 European countries partici-
pated (Fig. 1 and ESM table of collaborators). In addition, 
three ICUs from outside Europe also provided data.
Overall 5187 patients had a CRF completed, while 
5132 patients from Europe were included. Of European 
patients 5021 patients with a complete dataset could be 
analysed. Patient flow through the study is illustrated 
in the flow chart (ESM Fig. 3). The number of recruited 
patients varied from 1054 (UK 91 ICUs) to 6 (Czech 
Republic, one ICU). The median recruited patients per 
country was 114 and the median per ICU was 16.
Median age for all patients was 84  years (IQR 81–86) 
and 52.1% were male (ESM Table 2). Median LOS in hos-
pital before ICU admission was 1 day, and median ICU 
LOS was 2.3 days. Overall survival was 77.9% in the ICU 
and 67.6% at 30 days. ICU survival was lower (72.4%) in 
the subgroup of patients with an ICU LOS < 24 h (ESM 
Table 3). Patients dying within 24 h had very high SOFA 
score, and withholding or withdrawal of therapy was fre-
quent (ESM Table 4).
Data on frailty was available in 99.8% of admissions 
with a median value of 4 (IQR 3–6). Differences between 
not-frail, pre-frail and frail groups are depicted in 
Table 1. Frail patients were older, had higher SOFA score, 
were more often female, and more frequently therapy 
was withheld or withdrawn. The crude 30-day mortality 
for each frailty score (1–9) in elective and acute admit-
ted patients is shown in Fig. 2 with nearly linear relation-
ship between mortality and increased frailty in the acute 
admitted patients (Chi squared test for trend; p < 0.001).
The distribution of the 12 admission categories is 
shown in ESM Table  5. Respiratory and/or circulatory 
failure were the most frequent causes. Baseline data and 
outcomes for the admission groups are given in Table 2, 
regrouped into acute and elective admissions. Patients 
admitted electively had less organ failure and less mortal-
ity at ICU discharge and at 30 days.
The most frequent ICU procedures were the use of vas-
oactive drugs in 52.2% and invasive ventilation in 50.7%, 
NIV was used in 23% while RRT was used in 9.2% of all 
admissions. In 23.8% of the patients no ICU procedures 
were recorded.
Cox survival analysis (Table 3) gives the data on univar-
iate and multivariate analysis with corresponding hazard 
1823
ratios (HR). The highest HRs were found for acute ver-
sus elective admissions (4.72) with frail versus fit as the 
second (1.54). The HR for age per 5-year increase was 
1.2. The estimated 30-day survival rates for fit versus frail 
were 76% and 59%, respectively. Results of a subgroup 
analysis of acute admitted patients gave very similar 
results (see ESM Table  6A), and results from including 
five different European regions in the analysis are shown 
in ESM Table 6B.
Discussion
Along with the increase in life expectancy of the general 
population, the age of critically ill patients increases. The 
proportion of very elderly ICU patients exceeds 10% in 
Fig. 1 Participating countries, ICU numbers and included patients
Table 1 Comparison of three classes of frailty: not frail, pre-frail and frail
Data are presented as medians [interquartile range] or absolute numbers N (%)
Frailty score group descriptives Frailty 1–3: not frail Frailty 4: pre-frail Frailty 5–9: frail p value
N 1893 972 2156
Age 83 [81–86] 83 [81–86] 84 [82–87] < 0.001
Gender (male) 1100 (58.1%) 510 (52.5%) 1007 (46.7%) < 0.001
Unplanned admission 436 (23%) 211 (21.7%) 259 (12%) < 0.001
SOFA score at admission 6 [3–9] 6 [4–10] 7 [4–11] < 0.001
Region < 0.001
 Central 286 (15.1%) 174 (17.9%) 441 (20.5%)
 East 133 (7%) 111 (11.4%) 303 (14.1%)
 North 241 (12.7%) 131 (13.5%) 350 (16.2%)
 South 734 (38.8%) 310 (31.9%) 658 (30.5%)
 West 499 (26.4%) 246 (25.3%) 404 (18.7%)
ICU length of stay (days) 2.2 [1.0–5.6] 2.4 [1.0–6.0] 2.4 [1.0–6.0] 0.695
Treatment withheld 269 (14.2%) 206 (21.2%) 674 (31.3%) < 0.001
Treatment withdrawn 187 (9.9%) 106 (10.9%) 319 (14.8%) < 0.001
ICU survival 1558 (82.3%) 775 (79.7%) 1578 (73.2%) < 0.001
30-day survival 1431 (75.6%) 686 (70.6%) 1278 (59.3%) < 0.001
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many countries. However, the survival of this very old 
age group is rather poor [4, 5, 9]. One of the important 
gaps of knowledge is the short-term survival of these 
elderly ICU patients in relation to premorbid functioning 
[9]. Here, we present the first large transnational study 
to show the influence of frailty on 30-day mortality in a 
large group of ICU patients of 80  years and above. We 
found that increased degree of frailty, being admitted to 
the ICU in a non-elective fashion and high SOFA score at 
admission (per point) were the three most important fac-
tors associated with ICU mortality or 30-day mortality.
Many previous studies on survival in VIPs are retro-
spective, usually single-centre and often small [5]. In 
these studies case mix differences profoundly affect out-
come and ICU mortality ranges from 14% to 46% and 
hospital mortality from 28% to 48% [4, 13]. Unfortunately, 
fixed 30-day mortality is seldom reported since this infor-
mation is often difficult to retrieve in many countries. 
Only two studies reported 30-day mortality and this was 
found to be 34.6% and 35%, respectively [14, 15], which 
is similar to the overall 30-day mortality of 32.4% in our 
study. The ICU mortality in our study of 22.1% and the 
30-day mortality of 32.4% are in the same range as those 
previously published in prospective cohort from Canada: 
21.8% and 35%, respectively [16]. However, in that study 
patients with an anticipated ICU length of stay less than 
24 h were excluded. This may also explain the differences 
found in the LOS in these studies (median 4 days in the 
Canadian cohort versus 2.3  days in this study). Indeed, 
patients with a LOS less than 24  h were significantly 
more often admitted after planned surgery (see ESM 
Table  3). A striking finding was that ICU mortality was 
found to be higher in patients with shorter (< 24 h) ICU 
stay compared with longer stay. A potential explanation 
for this finding could be that many patients with uncer-
tain benefit from intensive care are admitted for “in-ICU 
triage” and, if found to be non-responsive regarding vital 
functions stabilization, treatment was stopped early.
We recruited 5132 very old intensive care patients 
from 21 European countries and found presence of frailty 
to be independently associated with 30-day mortality. 
Frailty has been defined as a clinical state of increased 
vulnerability from age-associated decline in physiologi-
cal reserves and function in a wide range of physiological 
systems [2]. This concept of frailty has been used by geri-
atricians showing an association with adverse outcomes 
including decline in functional performance, prolonged 
LOS, institutionalisation, and mortality. The concept of 
frailty has recently spread to other areas of medicine [17, 
18] and has been introduced as a potentially useful con-
cept in (elderly) ICU patients [19]. Using a frailty index, 
one study found a strong association between increased 
frailty and 90-day mortality [20]. In a Canadian study, a 
lower index on a frailty scale was independently associ-
ated with increased survival in 610 patients followed for 
12 months [4, 21]. A recent multicentre American study 
found an association between greater degree of frailty, 
measured with the Clinical Frailty Scale, and higher risk 
with increasing frailty on 3- and 12-month mortality [22]. 
That study did not specifically report results in the very 
old, but found frailty to be common, even in younger ICU 
patients. In our study, we found an association between 
Fig. 2 Association between frailty scale and 30-day outcome
Table 2 Comparison of elective versus acute admissions
Data are presented as medians [interquartile range] or absolute numbers N (%)
Admission Elective Acute p value
N 906 4115
Age 83 [81–86] 84 [81–87] < 0.001
Gender male 499 (55.1%) 2118 (51.5%) 0.054
SOFA score at admission 4 [2–7] 7 [4–11] < 0.001
Frailty scale < 0.001
 Frailty 1–3: not frail 436 (48.1%) 1457 (35.4%)
 Frailty 4: pre–frail 211 (23.3%) 761 (18.5%)
 Frailty 5–9: frail 259 (28.6%) 1897 (46.1%)
Region < 0.001
 Central 241 (26.6%) 660 (16%)
 East 84 (9.3%) 463 (11.3%)
 North 40 (4.4%) 682 (16.6%)
 South 257 (28.4%) 1445 (35.1%)
 West 284 (31.3%) 865 (21%)
ICU length of stay (days) 1.2 [0.9–2.9] 2.8 [1.1–6.5] < 0.001
Treatment withheld 42 (4.6%) 1107 (26.9%) < 0.001
Treatment withdrawn 15 (1.7%) 597 (14.5%) < 0.001
ICU survival 878 (96.9%) 3033 (73.7%) < 0.001
30-day survival 844 (93.2%) 2551 (62%) < 0.001
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Table 3 Survival analysis all patients (Cox model: all patients are censored at a maximum of 30 days)
HR (95% CI) p
Univariate analysis
 Frailty
  Vulnerable (4) vs fit (1–3) 1.24 (1.07–1.43) 0.005
  Frail (5–9) vs fit (1–3) 1.88 (1.67–2.1) < 0.001
 Frailty
  2 vs 1 1.33 (0.91–1.93) 0.136
  3 vs 1 1.27 (0.89–1.81) 0.187
  4 vs 1 1.56 (1.09–2.23) 0.014
  5 vs 1 1.97 (1.38–2.81) < 0.001
  6 vs 1 2.16 (1.51–3.08) < 0.001
  7 vs 1 3.08 (2.15–4.41) < 0.001
  8 vs 1 3.29 (2.20–4.92) < 0.001
  9 vs 1 4.50 (2.45–8.25) < 0.001
 Age
  5-year increase 1.21 (1.14–1.30) < 0.001
 Gender
  Male vs female 1.11 (1.01–1.22) 0.039
 SOFA score
  One-point increase 1.14 (1.13–1.16) < 0.001
 Type of admission
  Acute vs elective 6.72 (5.22–8.67) < 0.001
Multivariate analysis
 Frailty
  Vulnerable (4) vs fit (1–3) 1.19 (1.03–1.38) 0.021
  Frail (5–9) vs fit (1–3) 1.54 (1.38–1.73) < 0.001
 Age
  5-year increase 1.2 (1.12–1.28) < 0.001
 Gender
Male vs female 1.17 (1.06–1.29) 0.002
 SOFA score
  One-point increase 1.13 (1.12–1.14) < 0.001
 Type of admission
  Acute vs elective 4.72 (3.65–6.10) < 0.001
Acute admissions only (n = 4115)
 Frailty
  Vulnerable (4) vs fit (1–3) 1.18 (1.02–1.38) 0.031
  Frail (5–9) vs fit (1–3) 1.53 (1.36–1.72) < 0.001
 Age
  5-year increase 1.19 (1.12–1.28) < 0.001
 Gender
  Male vs female 1.17 (1.06–1.29) 0.002
 SOFA score
  One-point increase 1.13 (1.12–1.14) < 0.001
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30-day mortality and increased frailty using a slightly 
expanded nine-point frailty scale.
Survival at 30  days was, however, most affected by 
type of admission; acute admissions had the highest 
risk of dying. Obviously, this is the result of selection 
bias related to urgency of admission. Patients admit-
ted after planned surgery are younger, less frail and 
have a lower SOFA score on the first day of admission 
than patients after emergency admission. This selection 
of “better” and more prepared patients leads to lower 
mortality rates. Vice versa, the highest mortality was 
found after trauma, with a mortality of nearly 50% after 
30 days.
Other important factors that remained independently 
associated with 30-day survival after adjustment were 
the SOFA score, gender and age. Several severity of ill-
ness scores have been applied and shown to be associated 
with mortality in studies in a general (non-elderly) ICU 
population. However, none of these models was found 
sufficiently reliable to be used in the elderly ICU patients 
[23]. For example, in a prospective study of 1033 VIPs 
from Canadian ICUs, the researchers presented a risk 
score based on values present around ICU admission. A 
combination based on age, Glasgow Coma Score (GCS), 
serum creatinine and pH performed well with c-statistic 
of 0.72 [16]. However, risk prognostication in a criti-
cal ill elderly population is associated with other factors 
as well, factors more intimately associated with age like 
co-morbidity, activities of daily life, frailty, dementia and 
sarcopenia. Hence, severity scores that focus on physi-
ological abnormalities will probably not perform better 
than the general prognostic scoring systems in this group. 
Although we found an association between frailty and 
short-term outcomes, frailty alone cannot predict such 
outcomes. Strikingly, we found an association between 
frailty and SOFA score measured within the first 24 h of 
admission (see Table 1). The patients with a higher frailty 
class had more SOFA points. We hypothesized that this is 
caused by comorbidities present prior to ICU admission 
that, once the patient is admitted and critically ill, trans-
late or progress into more organ failure on the ICU. We 
think that this simple-to-use clinical frailty scale should 
be a natural candidate to include in a future composite 
risk score for (the very old) ICU patients.
Despite the rather short median ICU LOS, most of the 
VIPs in our study had a high admission SOFA score, and 
most received one or more organ support therapies. VIPs 
have previously been found to receive less active treat-
ment than their younger counterparts. From France the 
daily workload on VIPs compared to a group aged 65–80 
was found to be lower [24]; and a Norwegian study in 
elderly patients reported that mechanical ventilation is 
less often applied and with shorter duration than in an 
age group from 50 to 80 years: 40.6% vs 56.1% [25]. More 
recent data from Canada demonstrates higher treatment 
intensity and 72% of the VIPs received mechanical venti-
lation for a mean of 7.1 days [16]. Neither that study nor 
the present one has a comparison group, but both indi-
cate an increased therapeutic approach in the VIPs.
The strength of this study is the high number of criti-
cally ill VIPs recruited prospectively during a limited 
time period (8  months), hence reducing the effects of 
time bias on approach and attitude to treatment. It is also 
the first large transnational study in this particular age 
group. We included all ICU admissions, not only those 
with certain admissions or certain LOS; hence the results 
should have an acceptable external validity. On the other 
hand, there are several limitations. Since we deliberately 
made the study rather simple, we missed certain details 
of the patients, like co-morbidity and duration of organ 
support. The proportion of the VIPs for all separate 
ICUs was not recorded. We also have no long-term sur-
vival and functional outcome data in survivors. This was, 
however, not within the scope of this study. The chosen 
way of measuring frailty (clinical frailty scale) is subjec-
tive and may have a higher inter-rater variability than 
more objective measures of frailty. However, given the 
hectic circumstances around an acute admission in very 
old patients, there will never be time for more detailed 
screening like grip strength and walking speed, both 
important for the concept of frailty. Additionally, the 
evaluation of such measures is not feasible in most of the 
patients and might reflect the effect of the acute illness 
rather than the pre-admission frailty status.
Outcome = death in the first 30 days following ICU admission
N = 5021 patients with available data for outcome, frailty, age, gender, SOFA score and type of ICU admission
Table 3 continued
Survival estimates % (95% CI)
At 1 day At 3 days At 30 days
Fit 95% (94–96) 90% (89–92) 76% (74–78)
Vulnerable 95% (93–96) 90% (88–92) 71% (68–74)
Frail 92% (91–93) 85% (83–86) 59% (57–61)
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Conclusion
A simple frailty screening tool such as the Clinical Frailty 
Scale adds value to the global assessment of VIPs, and 
frailty is a significant factor for reduced 30-day survival. 
However, we found that acute ICU admission had the 
strongest impact on survival, while age had a smaller 
impact. Future studies are required to clarify how we can 
include frailty and its significance in ICU predictive scores.
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